Greetings from Tonya

I am so pleased to introduce you to Sarah Cannon Oncology Nursing Essentials (Sarah Cannon ONE), a comprehensive education series funded through HCA and Sarah Cannon. This HealthStream-based Blood Cancer and BMT Nursing Curriculum is designed to improve nursing competence and confidence in providing care to patients with complex diseases and intensive therapies. The modules are designed to be short (most are between 20 – 40 minutes), interactive, evidence-based, contain high-quality graphics and animation, and provide downloadable pocket guides to assist the nurse with patient assessment, education, psychosocial support and care.  

The first nine modules in the Sarah Cannon ONE curriculum soon to be released are:

  • CAR T-Cell Therapy: A New Frontier (Introduction)
  • CAR T-Cell Therapy: Toxicities
  • Hematologic Oncologic Emergencies I (4 modules)
    • Tumor Lysis Syndrome
    • Disseminated Intravascular Coagulation
    • ITP/TTP
    • Hyperleukocytosis/Hyperviscosity Syndrome
  • Professional Boundaries
  • Blood Cancer Overview
  • Acute Myelogenous Leukemia

We welcome your feedback on the modules and ideas about additional content needed.  To help us better meet your needs, you will see that each module starts with demographic questions and ends with outcome measurements. In addition, each multiple choice posttest question is written in the format of the OCN® and BMTCN® test format.

A special thank you to Kite, a Gilead Company, who allowed us use of their animation sequence for the CAR T-Cell Therapy Modules.

Tonya Cox BSN, RN, OCN®
Assistant Vice President
Blood Cancer Operations

Letter from Sarah Cannon ONE Project Editor

Oncology care is evolving at what seems to be an exponential rate, and it can be difficult for busy nurses to keep up with every innovation. Oncology nurses also face challenges that are unique to our practice: constantly evolving standards of care coupled with long-term patient relationships which can contribute to complex care issues. With the new Sarah Cannon Oncology Nursing Essentials (Sarah Cannon ONE), we hope to address some of these issues in a way that is quick, succinct and applicable to your everyday practice.

We will cover a wide range of topics from new treatment innovations and common blood cancers to maintaining professional boundaries to handling specific side effects and oncologic emergencies, equipping you with the knowledge and tools to become a well-rounded nurse. Content for each SC ONE module is unique in its ability to fit in with your busy schedule, as each module is designed as user driven, easy-to-digest segments with clear nursing implications. These interactive modules will challenge you to examine not only your own understanding of the content, but also how you express information to your patients. We hope that these modules will motivate you to make changes not only within your own practice, but to improve the overall quality of care in your facility.

As an oncology nurse consultant with over three decades of oncology nursing experience in both HCT (staff nurse and CNS) and medical writing/managing editor, I am beyond excited to be involved in the next big push towards quality oncology care at Sarah Cannon. I am especially grateful to have started with this project from the very beginning: in my role, I create and manage the development of each Sarah Cannon ONE module and provide input into the Sarah Cannon ONE curriculum.

I hope you find these modules to be both informative and engaging. We are always open to suggestions on how to improve our SC ONE curriculum, so do not hesitate to contact us at  

Elaine S. DeMeyer MSN, RN, AOCN®
Oncology Nurse Consultant

It takes a Village

Many of our nurse and interdisciplinary team members across the Sarah Cannon Blood Cancer Network Programs have collaborated to support the content development and review of the modules. Over the next several enewsletters, we will introduce you to the individuals who have contributed in the following roles:

  • Nurse Advisory Council: assure fairness/balance, accuracy and relevance of content, support content development as requested (SBAR communication, case studies); serve as champion within organization to promote awareness of module resources
  • Content Specialist: serves in the role of editor in chief to review each and every module for consistency in content, continuity with other existing resources, and evidence-based care
  • Faculty/Contributors: contribute to content development and provide expertise for individual modules; act as a clinical resource during manuscript development
  • Target Audience Reviewers: test the module for length of time, functionality, perspective of end user


Two CAR T-Cell Modules to be released in August

Module 1: CAR T-Cell Therapy: A New Frontier

Module 2: CAR T-Cell Therapy Toxicities


Module 1: CAR T-Cell Therapy: A New Frontier

Chimeric Antigen Receptor (CAR) T-Cell Therapy is a type of immune effector cell therapy that works by modifying T-cells to better identify and attack cancer cells. This module will help you better understand CAR T-Cell engineering, the six key steps in a CAR T-Cell clinical timeline, and future direction of CAR T-Cell Therapy.


Module 2: CAR T-Cell Therapy Toxicities

CAR T-Cell treatment is known to cause potentially life-threatening immune responses such as cytokine-release syndrome (or CRS) and CAR T-Cell-related encephalopathy syndrome (or CRES). This module will help you best identify, manage, educate, and support patients with CAR T-Cell toxicities.

Sarah Cannon ONE Faculty

Laura M. Todt, BSN, MPM, RN is the Director of the Blood Cancer Research Program at Sarah Cannon in Nashville, Tennessee. She has 15 years’ experience in the conduct, management, and oversight of oncology clinical trials.  Currently she supports the development of blood cancer research programs across the Sarah Cannon Blood Cancer Network, including Immune Effector Cell Therapy programs.

Lindsay Adkins, BSN, RN, BMTCN® has been an inpatient staff nursing at

Sarah Cannon Center for Blood Cancer at TriStar Centennial Medical Center in Nashville, Tennessee for six years. Lindsay has experience in the care of patients receiving CAR T-Cell Therapy and is currently enrolled in graduate school to obtain her Master’s of Science in Nursing degree.